Stock Offerings
Secondary · ATM · Shelf · PIPE Guide↗
1,208 results
1208
Total Filings
$7039.3B
Total Raised
101
424B4 Offerings
318
ATM Programs
257
PIPEs
| Date ▼ | Ticker | Sector | Industry | Mkt Cap | Type | Offer Price | Price | vs Offer | Shares | Proceeds | Underwriters | Summary |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 | BCHT | Industrials | Industrial - Pollution & Treatment Controls | $37M | Public Offering |
$2.40
floor
|
$1.40 | -41.7% | 6.2M | $15M | — | BirchTech Corp. is selling 6,250,000 common shares at $2.40 per share, raising $15 million gross proceeds for general corporate purposes and working capital. |
| Feb 26 | DUOT | Technology | Software - Application | $261M | Public Offering | — | $8.84 | — | — | — | — | Duos Technologies Group is offering an unspecified number of common shares at an undetermined price per share, with proceeds use not disclosed in this preliminary prospectus supplement. |
| Feb 26 | KTOS | Industrials | Aerospace & Defense | $8.0B | Public Offering | — | $42.69 | — | — | — | Raymond James, RBC Capital, Truist | Kratos Defense & Security Solutions is offering $1 billion in common stock at $88.23 per share (February 25, 2026 price) to raise capital, with a 30-day underwriter option for an additional $150 million. |
| Feb 26 | LRMR | Healthcare | Biotechnology | $332M | Public Offering |
$5.95
floor
|
$3.19 | -46.3% | 20.0M | $119M | J.P. Morgan, William Blair | Larimar Therapeutics is selling 20 million shares at $5.00 per share, raising $100 million gross proceeds ($94 million net), for general corporate purposes. |
| Feb 26 | VGZ | Basic Materials | Gold | $396M | Public Offering |
$2.83
floor
|
$2.71 | -4.2% | — | — | — | Vista Gold Corp suspends its at-the-market offering after selling $4.6 million of common shares since November 2024 under an $8 million registration; proceeds fund general corporate purposes. |
| Feb 26 | TLSIW | — | — | — | Public Offering | — | — | — | 9.8M | — | — | TriSalus Life Sciences offers 9,756,100 common shares at $4.10/share, raising $40 million gross ($37.6 million net), with proceeds for general corporate purposes. |
| Feb 26 | AAOI | Technology | Semiconductors | $8.0B | ATM |
$58.12
floor
|
$99.26 | +70.8% | — | — | Raymond James, Needham | Applied Optoelectronics is selling up to $250 million of common stock at-the-market through Raymond James and Needham at $58.12 per share; proceeds for general corporate purposes. |
| Feb 26 | PVLA | Healthcare | Biotechnology | $2.0B | Public Offering | — | $137.93 | — | — | — | Cowen, Stifel, Oppenheimer | Palvella Therapeutics is selling 1.6 million shares at $125 per share, raising $200 million gross ($188 million net after $12 million underwriting discount). |
| Feb 26 | SIDU | Industrials | Aerospace & Defense | $182M | ATM |
$2.03
floor
|
$1.81 | -10.8% | — | — | — | Sidus Space is conducting an at-the-market offering of up to $100 million in Class A common stock through ThinkEquity LLC at prevailing market prices, with proceeds for general corporate purposes. |
| Feb 26 | BCAX | Healthcare | Biotechnology | $1.2B | Public Offering | — | $18.61 | — | 7.2M | — | Cowen, BofA, Stifel | BCAX is offering 7,175,000 common shares and 2,200,000 pre-funded warrants at $16.00 and $15.9999 respectively, raising approximately $141 million in net proceeds for general corporate purposes. |
| Feb 26 | SMR | Utilities | Renewable Utilities | $2.4B | ATM | — | $7.90 | — | — | — | UBS, B. Riley | NuScale Power Corporation is selling up to $1 billion of Class A Common Stock through four sales agents at market prices, with proceeds for general corporate purposes. |
| Feb 26 | KYMR | Healthcare | Biotechnology | $9.2B | ATM | — | $111.79 | — | — | — | Cowen | Kymr will sell up to $500 million in common stock at-the-market through TD Cowen, with proceeds for general corporate purposes and a 3% sales commission. |
| Feb 26 | VIR | Healthcare | Biotechnology | $1.9B | Public Offering | — | $11.18 | — | 17.6M | — | Evercore, Barclays | Virologic (VIR) is offering 17,647,059 common shares at $8.50 per share for $150 million gross proceeds, with net proceeds of approximately $141.75 million before expenses. |
| Feb 26 | LPCN | Healthcare | Biotechnology | $18M | ATM | — | $2.24 | — | 1.6M | — | — | Lipocine Inc. (LPCN) is increasing its at-the-market offering to $50 million total common stock through A.G.P./Alliance Global Partners, with $39.4 million available for new sales after prior $10.6 million sold. |
| Feb 25 | RVMDW | — | — | — | ATM |
$102.74
floor
|
— | — | — | — | Cowen | Revmd may sell up to $1 billion in common stock at-the-market through TD Cowen, with last price $102.74/share; proceeds for general corporate purposes. |
| Feb 25 | LYTS | Technology | Hardware, Equipment & Parts | $762M | Public Offering |
$21.96
floor
|
$20.75 | -5.5% | — | — | Oppenheimer | # LYTS Offering Summary Lyts is raising $90 million through a common stock offering at an undisclosed price per share (last trade $21.96), with proceeds for unspecified corporate purposes. |
| Feb 25 | CISS | Industrials | Marine Shipping | $242,709 | ATM | — | $0.88 | — | — | — | — | C3IS Inc. is raising up to $98 million through at-the-market sales of common stock via Aegis Capital Corp., with proceeds for general corporate purposes. |
| Feb 25 | MCB | Financial Services | Banks - Regional | $1.1B | Public Offering |
$90.78
floor
|
$87.12 | -4.0% | — | — | UBS | Metropolitan Bank Holding Corp. is offering shares of common stock to raise $175 million for organic growth initiatives, bank investments, working capital, and general corporate purposes. |
| Feb 25 | RXRX | Healthcare | Biotechnology | $2.2B | ATM | — | $4.13 | — | — | — | Cowen | Recursion Pharmaceuticals is offering up to $300 million of Class A Common Stock at-the-market through TD Securities, with proceeds for general corporate purposes; stock trading at $3.53/share on February 24, 2026. |
| Feb 25 | HUT | Financial Services | Financial - Capital Markets | $9.7B | ATM | — | $86.10 | — | — | — | Cantor Fitzgerald, Needham, Stifel | HUT is issuing up to $1 billion in common stock through an at-the-market offering via multiple sales agents on Nasdaq and other venues, with proceeds for general corporate purposes. |
Data sourced from SEC EDGAR 424B4, 424B5, and 8-K filings. IPOs hidden by default.
Learn more →